Epista Life Science Cited by Gartner in Two Hype Cycles for Second Year in a Row

Epista Life Science is proud to announce our recognition as a Sample Vendor in two recent Gartner Hype Cycle Reports: Hype Cycle for Life Science Research and Development 2019(1) and Hype Cycle for Life Science Commercial Operations 2019(2). In both reports, Gartner identified Epista as a Sample Vendor for compliant GxP Cloud Services. Klavs Esbjerg, CEO of Epista, states:

“2019 marks 10 years of innovation and trust for Epista. We believe these citations confirm our commitment to turning compliance obstacles into opportunities, both for our clients and the entire Life Science industry.”

According to the ‘Compliant GxP Cloud Services’ technology category in both of the 2019 Hype Cycle reports, Gartner suggests the following user advice: “Develop a GxP cloud service strategy with stakeholders that fits with an overall company cloud business strategy before making any IT moves.” Furthermore, Gartner suggests the business impact of Compliant GxP Cloud Services as: “Adopting a GxP cloud service strategy can augment IT groups and organizations that lack validation capabilities. The costs and benefits, driven chiefly by automation, are particularly significant for small and midsize businesses who may lack the expertise, resources and infrastructure to maintain these environments.”

Epista is proud to be cited as a Sample Vendor for Compliant GxP Cloud Services. We believe opportunity lies with both maintaining the validated state of the Cloud service, and also in keeping the Cloud system top-tuned to support your business goals, even as it is continuously update by the vendor, as well. We’ve got experience with systems such as Veeva, Tracelink, Dynamics 365 and more, including automated testing.

Read more about the proven path to your future platform with Epista’s Pharma Cloud Transition solution.